Nardon, Chiara
 Distribuzione geografica
Continente #
NA - Nord America 907
EU - Europa 835
AS - Asia 383
AF - Africa 9
OC - Oceania 7
SA - Sud America 5
Totale 2.146
Nazione #
US - Stati Uniti d'America 898
IE - Irlanda 196
FR - Francia 183
SG - Singapore 172
CN - Cina 162
RU - Federazione Russa 141
SE - Svezia 128
DE - Germania 63
IT - Italia 52
GB - Regno Unito 34
FI - Finlandia 16
IR - Iran 12
AU - Australia 7
CA - Canada 7
ID - Indonesia 7
TG - Togo 7
JP - Giappone 5
NL - Olanda 4
IL - Israele 3
KR - Corea 3
PT - Portogallo 3
GR - Grecia 2
IN - India 2
KG - Kirghizistan 2
PL - Polonia 2
UA - Ucraina 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
BO - Bolivia 1
BR - Brasile 1
BY - Bielorussia 1
CH - Svizzera 1
CL - Cile 1
CR - Costa Rica 1
EE - Estonia 1
GE - Georgia 1
HK - Hong Kong 1
HU - Ungheria 1
KH - Cambogia 1
KZ - Kazakistan 1
LV - Lettonia 1
MA - Marocco 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
RO - Romania 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
TH - Thailandia 1
TR - Turchia 1
Totale 2.146
Città #
Chandler 318
Dublin 192
Singapore 141
Lawrence 60
Princeton 60
Beijing 55
Ashburn 54
Sindelfingen 51
Kent 48
New York 43
Southend 26
Verona 25
Boardman 17
Moscow 14
Helsinki 10
San Francisco 10
Leawood 9
Sacramento 9
Santa Clara 8
West Jordan 8
Jakarta 7
Lomé 7
Strasbourg 7
Lappeenranta 6
Toronto 6
Zanjan 6
Andover 5
Romola 5
Tokyo 5
Columbus 4
Dallas 4
Canberra 3
Melbourne 3
Seoul 3
Tel Aviv 3
Tuscaloosa 3
Washington 3
Amsterdam 2
Ann Arbor 2
Athens 2
Bishkek 2
Buffalo 2
Chicago 2
Chions 2
Fairfield 2
Livigno 2
Los Angeles 2
North Bergen 2
Nuremberg 2
Ragusa 2
San Mateo 2
Seattle 2
Tashkent 2
Trento 2
Warsaw 2
Almaty 1
Baku 1
Bangkok 1
Boydton 1
Bratislava 1
Brunswick 1
Buenos Aires 1
Dubai 1
Florence 1
Frankfurt am Main 1
Freetown 1
Guangzhou 1
Hanover 1
Henderson 1
Huainan 1
Hyderabad 1
Jinan 1
Kathmandu 1
Kelowna 1
Kochi 1
Las Vegas 1
Lima 1
London 1
Manila 1
Minsk 1
Monmouth Junction 1
Nashville 1
Oklahoma City 1
Oslo 1
Padova 1
Pavia 1
Phnom Penh 1
Redmond 1
Riga 1
Riyadh 1
San Giovanni Lupatoto 1
San José 1
Sant'Ambrogio di Valpolicella 1
Santiago 1
Scottsdale 1
Sopron 1
Sucre 1
Sydney 1
Tallinn 1
Tbilisi 1
Totale 1.319
Nome #
“Composti di coordinazione, sintesi, nanoformulazione ed uso degli stessi come antinfiammatori” 71
COMPOSTI DI COORDINAZIONE, SINTESI, NANOFORMULAZIONE ED USO DEGLI STESSI IN ONCOLOGIA (Ru, Ga) 65
Enantioselective Cytotoxicity of Chiral Diphosphine Ruthenium(II) Complexes Against Cancer Cells 63
COMPOSTI DI COORDINAZIONE, SINTESI, NANOFORMULAZIONE ED USO DEGLI STESSI IN ONCOLOGIA (Au, Cu) 63
Composti di coordinazione, sintesi, nanoformulazione ed uso degli stessi come antinfiammatori” n° domanda:102016000122377, brevetto per invenzione industriale (antiflogistic), 54
An excellence in medicinal inorganic chemistry: a portrait of the gold(I/III) complexes patented for therapeutic purposes from 2010 to 2015 53
Near Infared Circularly Polarized Luminescence from water stable organic nanoparticles containing a chiral Yb(III) complex 52
Editorial: Unravelling Copper-Regulatory Systems and Copper-Affected Pathways in Cancer Cells to Improve Current Therapies 46
Labelled micelles for the delivery of cytotoxic Cu(II) and Ru(III) compounds in the treatment of aggressive orphan cancers: design and biological in vitro data 46
Novel inorganic chemotherapeutics for cancer treatment 46
Cellular and Computational Studies of Proteasome Inhibition and Apoptosis Induction in Human Cancer Cells by Amino Acid Schiff Base-Copper Complexes 45
New comprehensive studies of a gold(III) Dithiocarbamate complex with proven anticancer properties: Aqueous dissolution with cyclodextrins, pharmacokinetics and upstream inhibition of the ubiquitin-proteasome pathway 45
CCK8 receptor-mediated cancer treatment strategies in target therapy 45
Au(III)-Proline derivatives exhibiting selective antiproliferative activity against HepG2/SB3 apoptosis-resistant cancer cells 44
Cutting-Edge Nanosystems for Biomedical Applications 44
Copper(II)- and Ruthenium(III)-based complexes with promising anticancer activity 44
New metal-based cancer-targeting chemotherapeutics 43
Synthesis, chemical characterization and cancer cell growth-inhibitory activities of Cu(ii) and Ru(iii) aliphatic and aromatic dithiocarbamato complexes 42
CuII and AuIII Complexes with Glycoconjugated Dithiocarbamato Ligands for Potential Applications in Targeted Chemotherapy 42
20S proteasome inhibition by gold(III)-based antitumor agents: from in vitro and in vivo studies to X-ray crystallography 42
Gold(III) complexes sensitize mitochondria of tumor cells to permeability transition 42
Biological studies on Au(III) peptidomimetics about to enter Phase I clinical trials 42
Cell and cell-free mechanistic studies on two gold(III) complexes with proved antitumor properties 41
Design and development of new metal-based biosensors for the early detection of cancer antigens in oncology 41
Gold-based peptidomimetics for a targeted anticancer therapy 41
Ln(III) Complexes Embedded in Biocompatible PLGA Nanoparticles as Potential Vis-to-NIR Optical Probes 38
A new strategy in chemotherapy: preliminary studies on Cu(II) complexes aimed at exploiting the enhanced copper uptake in malignancies 38
Beyond Platinums: Gold Complexes as Anticancer Agents 37
Gold complexes for therapeutic purposes: An updated Patent review (2010-2015) 37
DESIGN AND DEVELOPMENT OF NEW METAL-BASED BIOSENSORS FOR THE EARLY DETECTION OF CANCER ANTIGENS IN ONCOLOGY 37
Design and Development of new metal-based biosensors for the early detection of cancer antigens in oncology 36
Cutting-edge anticancer agents: gold-based peptidomimetics targeting peptide transporters 36
Preclinical activity of multiple-target gold(III)-dithiocarbamato peptidomimetics in prostate cancer cells and xenografts 35
Studio pilota sull’efficacia di una formulazione micellare contenente un complesso di Au(III) nel trattamento dell’artrite sperimentale da collagene nel topo 35
In vitro and in vivo anticancer activity of recently patented gold-based peptidomimetics targeting peptide transporters 34
Anticancer Gold(III) Peptidomimetics: From Synthesis to in vitro and ex vivo Biological Evaluations 33
CCK8 peptide-labeled Pluronic® F127 micelles as a targeted vehicle of gold-based anticancer chemotherapeutics 33
New lanthanide-based biosensors for the early detection of cancer antigens 31
NIR-emission from Yb(III)- and Nd(III)-based complexes in the solid state sensitized by a ligand system absorbing in a broad UV and visible spectral window 29
Effect of the Heteroaromatic Antenna on the Binding of Chiral Eu(III) Complexes to Bovine Serum Albumin 29
New insights into the mechanism of action of the gold(III) dithiocarbamato complex AuL12: upstream inhibition of the ubiquitin-proteasome pathway and encapsulation in natural polysaccharides 29
Ubiquitin-Proteasome System impairment by the Gold(III) complex derivative AuL12 28
Lanthanide‐Based Complexes Containing a Chiral trans‐1,2‐Diaminocyclohexane (DACH) Backbone: Spectroscopic Properties and Potential Applications 27
From cisplatin to world-shattering gold(III) anticancer agents 27
Gold(III) dithiocarbamate complexes induce cell death triggered by thioredoxin redox system inhibition, mitochondrial permeability increase, and activation of ERK pathway 26
Metal-based dithiocarbamato anticancer agents: an overview 24
Gold(III)-Dithiocarbamato Peptidomimetics in the Forefront of the Targeted Anticancer Therapy: Preclinical Studies against Human Breast Neoplasia 24
Promising Anticancer Mono- and Dinuclear Ruthenium(III) Dithiocarbamato Complexes: Systematic Solution Studies 24
Perspective gold(III)-dithiocarbamato anticancer therapeutics: learning from the past, moving to the future 23
Selective delivery of chemotherapeutics into tumor cells by use of targeting peptides 23
Leading-edge gold(III) targeted chemotherapeutics in translational oncology 22
Noble metal-dithiocarbamates: precious allies in the fight against cancer 21
New metal-based cancer-targeting chemotherapeutics 21
Gold(III) Complexes in the Oncological Preclinical Arena: from Aminoderivatives to Peptidomimetics 20
Targeting the ubiquitin-proteasome pathway with inorganic compounds to fight cancer: a challenge for the future 20
Gold(III)-pyrrolidinedithiocarbamato Derivatives as Antineoplastic Agents 19
Ru(III) anticancer agents with aromatic and non-aromatic dithiocarbamates as ligands: Loading into nanocarriers and preliminary biological studies 19
Target selective micelles for bombesin receptors incorporating Au(III)-dithiocarbamato complexes 19
Toward the selective delivery of chemotherapeutics into tumor cells by targeting peptide transporters: tailored gold-based anticancer peptidomimetics 18
Throwing light on recent advances on metallodrugs: From deemed poisons to a striking hope for the future 17
Is matching ruthenium with dithiocarbamato ligands a potent chemotherapeutic weapon in oncology? 17
Circularly Polarized Luminescence from New Heteroleptic Eu(III) and Tb(III) Complexes 16
Gold(III) to Ruthenium(III) Metal Exchange in Dithiocarbamato Complexes Tunes Their Biological Mode of Action for Cytotoxicity in Cancer Cells 12
Totale 2.216
Categoria #
all - tutte 12.613
article - articoli 6.818
book - libri 0
conference - conferenze 4.301
curatela - curatele 0
other - altro 0
patent - brevetti 1.097
selected - selezionate 0
volume - volumi 397
Totale 25.226


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022279 0 0 0 0 0 0 0 0 24 57 64 134
2022/2023967 87 117 90 177 54 242 1 55 116 5 13 10
2023/2024570 16 43 62 65 42 89 72 9 2 12 104 54
2024/2025400 44 92 45 191 28 0 0 0 0 0 0 0
Totale 2.216